Zurich - The medical technology start-up Peripal from the Greater Zurich Area has developed an auxiliary device to allow chronically ill kidney patients to carry out peritoneal dialysis within the comfort of their own homes. The system has now been authorized for the European market.
The number of chronically ill kidney patients is continually on the rise, according to a press release issued by Peripal. Moreover, the healthcare costs for patients suffering from renal insufficiency are disproportionately high. Home therapies could reduce costs here, while the majority of patients would also prefer treatment from within the comfort of their own homes. Nevertheless, the risk of infection and increasing age, among other factors, means that most patients currently opt for hospital-based dialysis.
An auxiliary device developed by Peripal for patients who require peritoneal dialysis is set to change this. The start-up developed this solution together with the Swiss Federal Institute of Technology in Zurich (ETH) as well as in close collaboration with patients. PeriSafe – as the device is named – can prevent infection and significantly simplify the treatment process, according to information provided by Peripal. The device has now received authorization for the European market.